Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndine Biomed Share News (OBI)

Share Price Information for Ondine Biomed (OBI)

Share Price is delayed by 15 minutes
Get Live Data
14.50    0.00 (0.00%)
Bid:
14.00
Ask:
15.00
Spread: 1.00 (7.143%)
Market Cap: £75.33m
OBI Live PriceLast checked at - London Stock Exchange

Intraday Ondine Biomed Share Chart

Ondine Biomed News

Ondine appoints new finance, operations chief
26 Feb 2025

Ondine appoints new finance, operations chief

(Sharecast News) - Ondine Biomedical announced the appointment of Michael Behlke as its chief financial and chief operating officer on Wednesday, stre...

AIM WINNERS & LOSERS: Tracsis wins UK rail deal; Ondine optimistic
19 Feb 2025

AIM WINNERS & LOSERS: Tracsis wins UK rail deal; Ondine optimistic

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.

Ondine Biomedical gets $4m investment from HCA Healthcare subsidiary
27 Jan 2025

Ondine Biomedical gets $4m investment from HCA Healthcare subsidiary

(Sharecast News) - Ondine Biomedical announced a $4m equity investment from hInsight-NX, a subsidiary of US medical facilities giant HCA Healthcare, o...

Ondine Biomedical shares slide as funding continues to be delayed
27 Jan 2025

Ondine Biomedical shares slide as funding continues to be delayed

(Alliance News) - Ondine Biomedical Inc on Monday said it expects its cash to last until the beginning of the fourth-quarter as it reported an equity ...

AIM WINNERS & LOSERS: hVIVO wins deal; Good Energy backs buyout
27 Jan 2025

AIM WINNERS & LOSERS: hVIVO wins deal; Good Energy backs buyout

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.

LONDON MARKET MIDDAY: Uninspiring trade as no Santa rally for FTSE 100
30 Dec 2024

LONDON MARKET MIDDAY: Uninspiring trade as no Santa rally for FTSE 100

(Alliance News) - London's FTSE 100 was in the red midday Monday, eating into a year-to-date gain that already pales in comparison to counterparts sta...

AIM WINNERS & LOSERS: Ondine Biomedical rises, Proton Power declines
30 Dec 2024

AIM WINNERS & LOSERS: Ondine Biomedical rises, Proton Power declines

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.

Ondine enrols first patient in phase three clinical trial
30 Dec 2024

Ondine enrols first patient in phase three clinical trial

(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surg...